COVID-19 Vaccine: ‘No Nigerian Has So Far Developed Severe Side Effects’ – NPHCDA


Over 400m Doses Of COVID-19 Vaccine Administered WorldwideNational Primary Health Care Development Agency (NPHCDA) has said there are currently no reports of severe side effects relating to the administration of AstraZeneca COVID-19 vaccine in the country.

Nigeria received its first batch of the AstraZeneca COVID-19 vaccine on March 2 and over 8,000 people have since been vaccinated across 35 states and Federal Capital Territory (FCT).

Read Also: EU Regulator Declares Oxford/AstraZeneca COVID-19 Vaccine Safe Following Blood Clot Reports Investigation

There have been reports on the development of blood clots in some recipients of the vaccine, causing several European countries to discontinue its use.

NPHCDA, however, assured Nigerians on the safety of the doses, stating that there is evidence showing that the vaccine does not cause blood clots and that the batch supplied to the country is safe.

Read Also: Nigeria Did Not Receive Batch Of AstraZeneca Vaccine Linked To Blood Clot – NPHCDA

In a tweet on Monday, NPHCDA noted that no one who has received the shot in Nigeria has so far presented any “severe side effects”.

It, however, did not state if mild effects have been reported.

The tweet reads;

FACT: No Nigerian so far has developed any known severe side effects following vaccination with AstraZeneca vaccine.

Leave A Reply

Your email address will not be published.